StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
NUVL

Nuvalent Inc

NUVL Nasdaq Pharmaceutical Preparations EDGAR ↗
$123.96

Key statistics

from XBRL data in SEC filings
Market cap
$9.75B
Revenue (TTM)
Net income (TTM)
-$450M
EPS (TTM)
$-6.06
P/E ratio
Dividend yield
Free cash flow
Cash
$160M
Total assets
$1.33B
Gross margin
52-week range
$71.13 – $123.99

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Completed an acquisition or disposition; Delisting notice or listing-rule failure; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws Jul 15, 2026 8-K Shareholder vote results Jun 18, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 9, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Other events Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Results of operations (earnings release) Jan 14, 2026 8-K Other events Dec 16, 2025 8-K Director or officer change Dec 10, 2025 8-K Entered a material agreement; Other events Nov 20, 2025 8-K Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Other events Sep 22, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Jul 21, 2025 8-K Other events Jun 24, 2025 8-K Director or officer change; Shareholder vote results Jun 20, 2025 8-K Director or officer change Jun 10, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Other events Jan 14, 2025 8-K Director or officer change Dec 9, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement; Other events Sep 17, 2024 8-K Other events Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Other events Jul 22, 2024 8-K Shareholder vote results Jun 14, 2024 8-K Other events May 16, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024